3//SEC Filing
Insight Holdings Group, LLC 3
Accession 0000950170-25-075955
CIK 0001673743other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 6:59 PM ET
Size
22.2 KB
Accession
0000950170-25-075955
Insider Transaction Report
Form 3
Insight Holdings Group, LLC
10% Owner
Holdings
- (indirect: See footnote)
Series C Preferred Stock
→ Common Stock (2,026,592 underlying) - (indirect: See footnote)
Series C-1 Preferred Stock
→ Common Stock (451,723 underlying) - (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (8,982,183 underlying) - (indirect: See footnote)
Series D Preferred Stock
→ Common Stock (819,106 underlying)
Footnotes (7)
- [F1]Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, will automatically convert and be reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation.
- [F2]Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities.
- [F3](Continued from footnote 2) Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein.
- [F4]Consists of (i) 4,485,644 shares held by IVP X, (ii) 3,678,282 shares held by IVP Cayman X, (iii) 711,528 shares held by IVP Delaware X, and (iv) 106,729 shares held by IVP X Co-Investors.
- [F5]Consists of (i) 1,012,067 shares held by IVP X, (ii) 829,907 shares held by IVP Cayman X, (iii) 160,537 shares held by IVP Delaware X, and (iv) 24,081 shares held by Insight Venture Partners X (Co-Investors).
- [F6]Consists of (i) 225,588 shares held by IVP X, (ii) 184,985 shares held by IVP Cayman X, (iii) 35,783 shares held by IVP Delaware X, and (iv) 5,367 shares held by IVP X Co-Investors.
- [F7]Consists of (i) 409,056 shares held by IVP X, (ii) 335,431 shares held by IVP Cayman X, (iii) 64,886 shares held by IVP Delaware X, and (iv) 9,733 shares held by IVP X Co-Investors.
Documents
Issuer
Hinge Health, Inc.
CIK 0001673743
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001305473
Filing Metadata
- Form type
- 3
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 6:59 PM ET
- Size
- 22.2 KB